Gallus BioPharmaceuticals | Ridgemont Equity Partners

industry sectors

Healthcare

status

Prior

headquarter city

St. Louis, MO

Year of investment

2011

overview

Gallus Biopharmaceuticals is a premier biologics contract manufacturing organization based in St. Louis, MO, which operates an FDA-approved, commercially-certified facility.

Visit Site

related news

DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus BioPharmaceuticals

Press Release / 8.27 Learn More

Ridgemont Equity Partners Acquires Majority Interest in Gallus BioPharmaceuticals

Press Release / 5.18 Learn More

View All